Show 1310: How Big Pharma Broke American Health Care
This week on our nationally syndicated radio show, Dr. John Abramson describes the impact of Big Pharma on American health care. In the US, we spend
This week on our nationally syndicated radio show, Dr. John Abramson describes the impact of Big Pharma on American health care. In the US, we spend
April 18, 2022 – A recent enforcement letter from the Food and Drug Administration’s (FDA’s) Office of Prescription Drug Promotion (OPDP) to
March 28, 2022 – As FDA Commissioner Robert Califf, M.D., determines how to fulfill his promise to re-examine the agency’s accelerated approval
Jan. 31. 2022 – Presenting drug benefit information without also including risk information in a social media post on Instagram misbrands Eli
Jan. 17, 2022 – A common theme among the enforcement letters issued by the FDA’s Office of Prescription Drug Promotion (OPDP) is the manner in
June 29, 2021 – In the wake of the FDA granting a controversial accelerated approval for Biogen’s aducanumab (Aduhelm) – and Biogen’s
June 21, 2021 – Amid increased scrutiny of its accelerated approval pathway – partly prompted by the recently rescinded approval for two oncology
May 24, 2021 – The FDA’s Office of Prescription Drug Promotion (OPDP) is preparing to study whether consumers are challenged when multiple
March 8, 2021 – Pharmaceutical companies and other healthcare stakeholders who utilize programmatic advertising are unintentionally placing ads
I have a confession to make. I am not a big fan of prescription drug advertising on TV. That includes drugs like Humira for Crohn’s disease,
Have you ever watched prescription drug commercials on television? It’s hard NOT to. They have proliferated like weeds after a spring rain.
One of the most remarkable things on television these days is drug advertisements. These commercials usually include long lists of potentially very